Joseph P. Nathan

460 total citations
26 papers, 323 citations indexed

About

Joseph P. Nathan is a scholar working on Geriatrics and Gerontology, Family Practice and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Joseph P. Nathan has authored 26 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Geriatrics and Gerontology, 6 papers in Family Practice and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Joseph P. Nathan's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Medication Adherence and Compliance (6 papers) and Pharmaceutical studies and practices (5 papers). Joseph P. Nathan is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Medication Adherence and Compliance (6 papers) and Pharmaceutical studies and practices (5 papers). Joseph P. Nathan collaborates with scholars based in United States, France and Israel. Joseph P. Nathan's co-authors include Jack M. Rosenberg, Fotios M. Plakogiannis, Elizabeth Kudadjie-Gyamfi, Catherine Smith, Einat Gorelik, Bruce Kirkham, Catherine Hughes, Bina Menon, Andrew Pink and Matitiahu Berkovitch and has published in prestigious journals such as British Journal of Clinical Pharmacology, Arthritis & Rheumatology and Annals of Pharmacotherapy.

In The Last Decade

Joseph P. Nathan

22 papers receiving 303 citations

Peers

Joseph P. Nathan
Matthew J. Seamon United States
Dinesh Kumar Upadhyay Nepal
Irma Melyani Puspitasari Indonesia
Lorenzo Villa Zapata United States
Kimberly Braxton Lloyd United States
Saied Eslami Netherlands
Robert D. Beckett United States
Gerri Kaufman United Kingdom
Hyla H. Polen United States
Annemieke Floor‐Schreudering Netherlands
Matthew J. Seamon United States
Joseph P. Nathan
Citations per year, relative to Joseph P. Nathan Joseph P. Nathan (= 1×) peers Matthew J. Seamon

Countries citing papers authored by Joseph P. Nathan

Since Specialization
Citations

This map shows the geographic impact of Joseph P. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph P. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph P. Nathan more than expected).

Fields of papers citing papers by Joseph P. Nathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph P. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph P. Nathan. The network helps show where Joseph P. Nathan may publish in the future.

Co-authorship network of co-authors of Joseph P. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph P. Nathan. A scholar is included among the top collaborators of Joseph P. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph P. Nathan. Joseph P. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nathan, Joseph P., et al.. (2024). Appropriateness of ChatGPT as a resource for medication‐related questions. British Journal of Clinical Pharmacology. 90(10). 2691–2695. 6 indexed citations
2.
Hughes, Catherine, Joseph P. Nathan, Andrew Pink, et al.. (2023). Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin‐4/13 Inhibitor. Arthritis & Rheumatology. 75(10). 1793–1797. 13 indexed citations
3.
Nathan, Joseph P., et al.. (2023). Treatment of gangrenous digit-threatening paraneoplastic acrocyanosis with vasodilator therapy. BMJ Case Reports. 16(2). e251417–e251417.
4.
Nathan, Joseph P., et al.. (2022). Prevagen®: Analysis of Clinical Evidence and Its Designation as a “#1 Pharmacist Recommended Brand”. The Senior Care Pharmacist. 37(8). 335–338.
5.
Nathan, Joseph P., et al.. (2019). Survey of drug information centers in the United States—2018. American Journal of Health-System Pharmacy. 77(1). 33–38. 2 indexed citations
6.
Nathan, Joseph P., et al.. (2018). Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel. Israel Journal of Health Policy Research. 7(1). 59–59. 5 indexed citations
7.
Berkovitch, Matitiahu, et al.. (2017). Pharmacovigilance in Israel – tools, processes, and actions. Israel Journal of Health Policy Research. 6(1). 29–29. 8 indexed citations
8.
Nathan, Joseph P., et al.. (2017). Pharmacy in Israel. American Journal of Health-System Pharmacy. 75(1). e57–e61. 2 indexed citations
9.
Nathan, Joseph P.. (2013). Drug Information—The Systematic Approach. Journal of Pharmacy Practice. 26(2). 78–84. 6 indexed citations
10.
Nathan, Joseph P., et al.. (2012). Professional Reading Habits of Pharmacists Attending 2 Educational Seminars in New York City. Journal of Pharmacy Practice. 25(6). 600–605.
11.
Nathan, Joseph P., et al.. (2011). Functions performed by paid pharmacy interns in hospitals in New York. American Journal of Health-System Pharmacy. 68(2). 165–168. 6 indexed citations
12.
Rosenberg, Jack M., et al.. (2009). Update on the status of 89 drug information centers in the United States. American Journal of Health-System Pharmacy. 66(19). 1718–1722. 26 indexed citations
13.
Nathan, Joseph P., et al.. (2009). Responding to drug information requests. American Journal of Health-System Pharmacy. 66(8). 706–711. 6 indexed citations
14.
15.
Nathan, Joseph P., et al.. (2005). Availability of and Attitudes Toward Resources on Alternative Medicine Products in the Community Pharmacy Setting. Journal of the American Pharmacists Association. 45(6). 734–739. 30 indexed citations
16.
Rosenberg, Jack M., et al.. (2004). Current status of pharmacist-operated drug information centers in the United States. American Journal of Health-System Pharmacy. 61(19). 2023–2032. 58 indexed citations
17.
Nathan, Joseph P., et al.. (2004). Strategies for the prevention and treatment of statin-induced myopathy: Is there a role for ubiquinone supplementation?. American Journal of Health-System Pharmacy. 61(5). 515–519. 18 indexed citations
18.
Nathan, Joseph P., et al.. (2003). Impact of aspirin on the gastrointestinal-sparing effects of cyclooxygenase-2 inhibitors. American Journal of Health-System Pharmacy. 60(4). 392–394. 1 indexed citations
19.
Rosenberg, Jack M., Joseph P. Nathan, & Fotios M. Plakogiannis. (2002). Weight Variability of Pharmacist-Dispensed Split Tablets. Journal of the American Pharmaceutical Association (1996). 42(2). 200–205. 52 indexed citations
20.
Nathan, Joseph P. & Jack M. Rosenberg. (2000). A Survey of Fee-for-Service Activities of Drug Information Centers. Hospital Pharmacy. 35(8). 837–840. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew J. Seamon Breakdown of academic impact, for papers by Dinesh Kumar Upadhyay Breakdown of academic impact, for papers by Irma Melyani Puspitasari Breakdown of academic impact, for papers by Lorenzo Villa Zapata Breakdown of academic impact, for papers by Kimberly Braxton Lloyd Breakdown of academic impact, for papers by Saied Eslami Breakdown of academic impact, for papers by Robert D. Beckett Breakdown of academic impact, for papers by Gerri Kaufman Breakdown of academic impact, for papers by Hyla H. Polen Breakdown of academic impact, for papers by Annemieke Floor‐Schreudering
Rankless by CCL
2026